Prosecution Insights
Last updated: May 29, 2026

K&L Gates Llp-Boston

22 pending office actions • 14 clients • 22 examiners • 20 art units • 0 of 22 (0%) have an AI response strategy ready • 18 patents granted in the last 365 days

Portfolio Summary

22
Total Pending OAs
12
Non-Final OAs
10
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 22 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

14
Overdue
0
Due this week
4
Due this month
4
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 22 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (14)Due ≤ 30 days (4)Due ≤ 60 days (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (18%)
13
Medium (59%)
1
Easy (5%)
4
Unknown (18%)

Rejection Statute Mix

BucketCases
§101 only4 (18%)
§103 only11 (50%)
§102 only2 (9%)
§112 only1 (5%)
No statute on record4 (18%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

13
Life Sciences
59% of docket
1
Information Tech
5% of docket
1
Communications
5% of docket
1
Semiconductors
5% of docket
6
Mechanical / Eng
27% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

220 h
Manual time on pending OAs
44 h
Time saved (low, 20%)
77 h
Time saved (mid, 35%)
1.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NORRIS, CLAIRE A 1 65.6% +28.0%
VETTER, DANIEL 1 19.6% +9.1%
GILL, RACHEL B 1 65.6% +27.7%
YU, HENRY W 1 69.0% +29.1%
TRA, TUYEN Q 1 86.0% +10.2%
LEE, CHIHYI NMN 1 32.5% +62.8%
KOMATSU, LI N 1 59.5% +70.8%
ARIETI, RUTH SOPHIA 1 45.2% +73.6%
VANHORN, ABIGAIL LOUISE 1 46.7% +22.1%
ROBINSON, MIKHAIL O'DONNEL 1 56.8% +41.6%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18570445 SYSTEM FOR MEASUREMENT OF PERIPHERAL ABERRATION TRA, TUYEN Q 44d overdue

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17363548 METHOD AND SYSTEM OF ENTITY INTERACTION HISTORY SIGNATURES ANDREI, RADU 86d overdue
16825087 Systems and Methods of Generating Patient Notes with Inherited Preferences WINSTON III, EDWARD B 60d overdue
18596511 SKILL LEVEL INFERENCE USING MACHINE LEARNING VETTER, DANIEL 25d overdue
16507521 METHOD AND SYSTEM TO AUTOMATE THE DESIGNATION OF THE INTERNATIONAL CLASSIFICATION OF DISEASE CODES FOR A PATIENT PAULS, JOHN A 11d overdue

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18399493 INFRASTRUCTURE INDEPENDENT SELF-CONFIGURING MANAGEMENT NETWORK YU, HENRY W 81d overdue
18643059 MAGNETIC FILTER APPARATUS AND METHOD NORRIS, CLAIRE A 60d overdue
18570445 SYSTEM FOR MEASUREMENT OF PERIPHERAL ABERRATION TRA, TUYEN Q 44d overdue
18248974 RNA COMPOSITIONS AND METHODS FOR INHIBITING LIPOPROTEIN(A) ARIETI, RUTH SOPHIA 3d overdue
18025307 SENOLYTIC COMPOUNDS AND COMPOSITIONS ROBINSON, MIKHAIL O'DONNEL 14d
18248988 NOVEL LIGANDS FOR ASIALOGLYCOPROTEIN RECEPTOR VANHORN, ABIGAIL LOUISE 20d
18282082 QUINAZOLINE-BASED COMPOUND, COMPOSITION, AND APPLICATION OF QUINAZOLINE-BASED COMPOUND LEE, CHIHYI NMN 36d
18420532 FORMULATIONS OF ANTIBODY MOLECULES TO DENGUE VIRUS GILL, RACHEL B 46d

Client Portfolio (14 clients)

Top Art Units

Art UnitApps
17792
36832
36281
16711
21811
28721
16281
16581
16351
16361

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18643059 MAGNETIC FILTER APPARATUS AND METHOD Medisieve Ltd. NORRIS, CLAIRE A 1779 §103 Non-Final OA 60d overdue Pending Apr 23, 2024
18596511 SKILL LEVEL INFERENCE USING MACHINE LEARNING Skyhive Technologies Holdings Inc. VETTER, DANIEL 3628 §101 Final Rejection 25d overdue Pending Mar 05, 2024
18420532 FORMULATIONS OF ANTIBODY MOLECULES TO DENGUE VIRUS VISTERRA, INC. GILL, RACHEL B 1671 §102 Final Rejection 46d Pending Jan 23, 2024
18399493 INFRASTRUCTURE INDEPENDENT SELF-CONFIGURING MANAGEMENT NETWORK Stratus Technologies Ireland Ltd. YU, HENRY W 2181 §103 Final Rejection 81d overdue Pending Dec 28, 2023
18570445 SYSTEM FOR MEASUREMENT OF PERIPHERAL ABERRATION UNIVERSITY COLLEGE DUBLIN TRA, TUYEN Q 2872 §102 Non-Final OA 44d overdue Pending Dec 14, 2023
18282082 QUINAZOLINE-BASED COMPOUND, COMPOSITION, AND APPLICATION OF QUINAZOLINE-BASED COMPOUND BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED LEE, CHIHYI NMN 1628 §103 Non-Final OA 36d Pending Sep 14, 2023
18037505 ERYTHROPOIETIN VARIANTS AND USES THEREOF Chulabhorn Foundation KOMATSU, LI N 1658 §103 Non-Final OA 56d Pending May 17, 2023
18248974 RNA COMPOSITIONS AND METHODS FOR INHIBITING LIPOPROTEIN(A) Sanofi ARIETI, RUTH SOPHIA 1635 Other Non-Final OA 3d overdue Pending Apr 13, 2023
18248988 NOVEL LIGANDS FOR ASIALOGLYCOPROTEIN RECEPTOR Sanofi VANHORN, ABIGAIL LOUISE 1636 Other Non-Final OA 20d Pending Apr 13, 2023
18025307 SENOLYTIC COMPOUNDS AND COMPOSITIONS Nuchido Limited ROBINSON, MIKHAIL O'DONNEL 1627 §103 Non-Final OA 14d Pending Mar 08, 2023
18019728 ANTI-CLAUDIN 18.2 MULTI-SPECIFIC ANTIBODIES AND USES THEREOF Abpro Corporation BRISTOL, LYNN ANNE 1643 Other Final Rejection 10d overdue Pending Feb 03, 2023
18018078 METHODS OF PREPARING SOLID PARTICULATE MATERIALS Micropore Technologies Limited HUANG, RYAN 1777 §103 Non-Final OA 107d overdue Pending Jan 26, 2023
18016143 METHOD OF PREPARING LIPID VESICLES Micropore Technologies Limited SHOMER, ISAAC 1612 §103 Non-Final OA 20d Pending Jan 13, 2023
17927497 MEMBRANE EMULSIFICATION APPARATUS WITH REFINER AND METHOD OF PREPARING A REFINED EMULSION Micropore Technologies Limited BASS, DIRK R 1779 §103 Final Rejection 12d Pending Nov 23, 2022
17730900 Automated Healthcare Provider Quality Reporting System (PQRS) Modernizing Medicine, Inc. HEIN, DEVIN C 3686 §103 Final Rejection 99d overdue Pending Apr 27, 2022
17364497 METHOD AND SYSTEM OF GUIDING A USER ON A GRAPHICAL INTERFACE WITH COMPUTER VISION Edcast Inc. BROUGHTON, KATHLEEN M 2661 §103 Final Rejection 15d overdue Pending Jun 30, 2021
17363548 METHOD AND SYSTEM OF ENTITY INTERACTION HISTORY SIGNATURES Edcast Inc. ANDREI, RADU 3698 §101 Final Rejection 86d overdue Pending Jun 30, 2021
16980207 METHOD OF TREATMENT Nuchido Limited OLSON, ANDREA STEFFEL 1693 Other Non-Final OA 73d overdue Pending Sep 11, 2020
16849141 Apparatus and Method for Assessment of Patient Condition Modernizing Medicine, Inc. NAJARIAN, LENA 3687 §103 Non-Final OA 34d Pending Apr 15, 2020
16825087 Systems and Methods of Generating Patient Notes with Inherited Preferences Modernizing Medicine, Inc. WINSTON III, EDWARD B 3683 §101 Final Rejection 60d overdue Pending Mar 20, 2020
16631861 METHODS AND COMPOSITIONS FOR TREATING ADDICTIONS BAR ILAN UNIVERSITY HILL, KEVIN KAI 1638 §112 Final Rejection 3d overdue Pending Jan 17, 2020
16507521 METHOD AND SYSTEM TO AUTOMATE THE DESIGNATION OF THE INTERNATIONAL CLASSIFICATION OF DISEASE CODES FOR A PATIENT Modernizing Medicine, Inc. PAULS, JOHN A 3683 §101 Non-Final OA 11d overdue Pending Jul 10, 2019

Managing K&L Gates Llp-Boston's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month